D Lebel
Overview
Explore the profile of D Lebel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bleuse A, Chabut C, Roy H, Lebel D, Ovetchkine P, Blackburn J, et al.
Ann Pharm Fr
. 2021 Sep;
80(4):576-583.
PMID: 34481782
Background: Different measures of antimicrobial are used to ensure proper usage, as part of structured antimicrobial stewardship programs. Objective: The main objective of this study is to describe the consumption...
2.
Videau M, Aussedat M, Leboucher G, Lebel D, Bussieres J
Ann Pharm Fr
. 2021 Aug;
80(3):312-326.
PMID: 34425078
Objectives: The objective was to describe the trends in the consumption of narcotic drugs, substances related to narcotic drugs (SAS) and psychotropic drugs between a French hospital and a Quebec...
3.
Marquot G, Frison C, Lebel D, Bussieres J, Metras M
Ann Pharm Fr
. 2020 Aug;
78(5):447-457.
PMID: 32777298
Introduction: Pharmacogenetics represents an opportunity in pharmaceutical practice. There are many documentary resources to support the pharmacist's work in this area. Objective: To compare the recommendations for carrying out pharmacogenetic...
4.
Soyer J, Necsoiu D, Desjardins I, Lebel D, Bussieres J
Arch Pediatr
. 2019 Oct;
26(7):400-406.
PMID: 31611146
Objective: To identify the discrepancies between the adverse drug reactions (ADRs) identified by medical records technicians and the ADRs identified by the pharmacovigilance team, and to validate the quality of...
5.
Chabrier A, Lebel D, Bussieres J
Ann Pharm Fr
. 2019 Oct;
77(6):496-505.
PMID: 31564420
Objectives: The objective was to identify the main texts applicable to the practice of pharmacy in Quebec, then count the specific number of recommendations and criteria and describe the evolution...
6.
Videau M, Lebel D, Bussieres J
Ann Pharm Fr
. 2019 Jan;
77(3):205-211.
PMID: 30670298
Objectives: Many signs point to the growing importance of drug shortages in Canada and around the world. Although drug shortages affect clinicians and patients every day, there is a paucity...
7.
Ferrand E, Odou P, Lebel D, Bussieres J
Ann Pharm Fr
. 2019 Jan;
77(3):250-263.
PMID: 30665679
Objectives: Evaluate the level of knowledge and perceptions of French and Quebec hospital's pharmacists/residents about bibliometrics indicators applied in pharmacy. Identify the determinants associated with this knowledge. Methods: This is...
8.
Ferrand E, Lariviere V, Lebel D, Bussieres J
Ann Pharm Fr
. 2019 Jan;
77(1):1-14.
PMID: 30636676
There are several indicators to evaluate the impact of the scientific publication in pharmacy. Given their number, complexity, heterogeneity, strengths and weaknesses, we believe that pharmacists are not sufficiently familiar...
9.
Harry M, Lebel D, Comtois A, Bussieres J
Arch Pediatr
. 2017 Nov;
24(12):1179-1187.
PMID: 29169713
Introduction: In view of the underdeclaration of adverse drug reactions (ADRs), there is a need for optimizing their reporting. To improve our declaration, a pharmacovigilance program was started in 2006 ...
10.
Guerin A, Leroux A, Lebel D, Bussieres J
Ann Pharm Fr
. 2016 Aug;
74(6):448-452.
PMID: 27475311
Objectives: The main objective was to evaluate the rate of publications with at least one indicator of the negative impact of clinical pharmaceutics activity. Methods: This is a descriptive and...